SCINO PHARMA TAIWAN LTD

Business Nature: Manufacturer

Company Overview:

ScinoPharm Taiwan Ltd. is a leading process research and development (PRD) and active pharmaceutical ingredient (API) manufacturing company. Founded in 1997, the company specializes in the development and production of high-quality APIs for the global pharmaceutical industry. It operates state-of-the-art manufacturing facilities that comply with international regulatory standards, including those set by the US FDA, EMA, and other major health authorities. ScinoPharm provides integrated services ranging from early-stage chemical process development and pilot-scale production to large-scale commercial manufacturing, as well as contract manufacturing services for complex injectable products.

SCINO PHARMA TAIWAN LTD Product Portfolio

Core Business Areas:

1. Active Pharmaceutical Ingredients (APIs)

2. Finished Dosage Forms (FDFs)

3. Contract Development and Manufacturing Organization (CDMO) Services

Key Product Categories and Therapeutic Areas:

Oncology and Hematology:

- Various high-potency API substances for cancer treatment

- Specialized injectable formulations for chemotherapy

Cardiovascular System:

- Agents for hypertension management

- Lipid-lowering medications

Central Nervous System (CNS):

- Neuro-modulating agents

- Specialized therapeutic compounds for neurological disorders

Metabolic Diseases:

- Medications for diabetes management

- Metabolic enzyme regulators

Specialized Delivery Systems:

- Lyophilized (freeze-dried) injectable products

- Complex sterile formulations

CDMO Services:

- Process development and scale-up for complex APIs

- Analytical method development and validation

- Regulatory filing support for global markets (US FDA, EU EMA, TFDA)

- Manufacturing of clinical trial materials and commercial batches